Lipid-lowering therapies – strengths, weaknesses, opportunities, threats
There's a strong evidence base for the safety and tolerability of many lipid-lowering drugs, including cholestyramine, statins, ezetimibe, PCSK9's and bempedoic acid
An understanding of:
- The evidence demonstrating safety and efficacy of many lipid-lowering therapies
- Factors that have an impact on trends in cardiovascular disease morbidity and mortality, and the roles of prevention and intervention strategies
- New lipid-lowering therapies currently available and new therapeutic targets currently under investigation
- Contemporary treatment of dyslipidaemia
To access this module, please register or login: